Antitumor effects of zerumbone from Zingiber zerumbet in P-388D1 cells in vitro and in vivo

Planta Medica

Volumn 71, Issue 3, 2005, Pages 219-224

  Huang, Guan Cheng ^a   Chien, Ting Yi ^b   Chen, Lih Geeng ^c   Wang, Ching Chiung ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

Antitumor; Cell cycle; P 388D1 cell; Zerumbone; Zingiber zerumbet; Zingiberaceae

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALCOHOL; ANTINEOPLASTIC AGENT; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; DNA FRAGMENT; ETHER; PLANT EXTRACT; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG; ZERUMBONE; ZINGIBER ZERUMBET EXTRACT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOASSAY; CELL CYCLE G2 PHASE; COLUMN CHROMATOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG ISOLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MEDICINAL PLANT; MITOSIS INHIBITION; MOUSE; NONHUMAN; RHIZOME; STRUCTURE ACTIVITY RELATION; TAIWAN; TIME; TRADITIONAL MEDICINE; ZINGIBER ZERUMBET;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MICE; PHYTOTHERAPY; PLANT EXTRACTS; RHIZOME; ZINGIBERACEAE;

EID: 16444363611     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837820     Document Type: Article

References (20)

1. Surh Y. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999; 428: 305-27
2. Tanaka T, Shimizu M, Kohno H, Yoshitani S, Tsukio Y, Murakami A, Safitri R, Takahashi D, Yamamoto K, Koshimizu K, Ohigashi H, Mori H. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci 2001; 69: 1935-45
3. Chiu NY, Chang KH. The illustrated medicinal plants of Taiwan. 1995: 2, 285
4. Damodaran NP, Sukh D. Studies in sesquiterpenes-XXX sesquiterpenes from the essential oil of Zingiber zerumbet Smith. Tetrahedron 1968; 24: 4113-22
5. Matthes HWD, Luu B, Ourisson G. Cytotoxic compounds of Zingiber zerumbet, Curcuma zedoaria and C. domestica. Phytochemistry 1980; 19: 2643-50
6. Masuda T, Jitoe A, Kato S, Nobuji N. Acetylated flavonol glycosides from Zingiber zerumbet. Phytochemistry 1991; 20: 2391-2
7. Murakami A, Takahashi M, Jiwajinda S, Koshimizu K, Ohigashi H. Identification of zerumbone in Zingiber zerumbet Smith as a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation. Biosci Biotechnol Biochem 1999; 63: 1811-2
8. Murakami A, Takahashi D, Kinoshita T, Koshimizu K, Kim HW, Yoshihiro A, Nakamura Y, Jiwajinda S, Terao J, Ohigashi H. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the alpha, beta-unsaturated carbonyl group is a prerequisite. Carcinogenesis 2002; 23: 795-802
9. Chen FC, Liu YT, Chen HY, Lee W, Lin HC, Wu CH, King ML. Mouse lymphocytic leukemia P388 for screening antitumor agents from crude plant extracts and fermentation broth. Chin Pharm J 1992; 44: 381-8
10. Gebhardt R. In vitro screening of plant extracts and phytopharmaceuticals: novel approaches for the elucidation of active compounds and their mechanisms. Planta Med 2000; 66: 99-105
11. Kitayama T, Okamoto T, Hill RK, Kawai Y, Takahashi S, Yonemori S, Yamamoto Y, Ohe K, Uemura S, Sawada S. Chemistry of zerumbone. 1. Simplified isolation, conjugate addition reactions, and a unique ring contracting transannular reaction of its dibromide. J Org Chem 1999; 64: 2667-72
12. Bruggisser R, Daeniken KV, Jundt G, Schaffner W, Tullberg-Reinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med 2002; 68: 445-8
13. Wang CC, Chen LG, Yang LL. Cytotoxic activity of sesquiterpenoids from Atractylodes ovata on leukemia cell lines. Planta Med 2002; 68: 204-8
14. Yang LL, Chang CC, Chen LG, Wang CC. Antitumor principle constituents of Myrica rubra van acuminate. J Agric Food Chem 2003; 51: 2974-9
15. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989; 246: 629-34
16. Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001; 1: 222-31
17. Jackman M, Lindon C, Nigg EA, Pines J. Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Bill 2003; 5: 143-8
18. Murakami A, Takahashi D, Koshimizu K, Ohigashi H. Synergistic suppression of superoxide and nitric oxide generation from inflammatory cells by combined food factors. Mutat Res 2003; 523: 151-61
19. Liao YH, Houghton PJ, Hoult JR. Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation. J Nat Prod 1999; 62: 1241-5
20. Murakami A, Tanaka T, Lee JY, Surh YJ, Kim HW, Kawabata K, Nakamura Y, Jiwajinda S, Ohigashi H. Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. Int J Cancer 2004; 110: 481-90